154 related articles for article (PubMed ID: 3709212)
1. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
Perego MA; Sergio G; Artale F; Giunti P; Danese C
Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Benignetti G; Fabbri F; Benvenuti C
Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
[No Abstract] [Full Text] [Related]
3. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
Störmer B; Kleinschmidt F; Loose D; Kremer K
Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Ehrly AM
Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
6. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
[No Abstract] [Full Text] [Related]
7. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
8. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
[TBL] [Abstract][Full Text] [Related]
9. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Runge E; Thiele P
Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
[TBL] [Abstract][Full Text] [Related]
10. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
Ehrly AM
J Med; 1979; 10(5):331-8. PubMed ID: 294470
[No Abstract] [Full Text] [Related]
11. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
12. Blood flow properties and walking performance in chronic arterial occlusive disease.
Angelkort B; Spürk P; Habbaba A; Mähder M
Angiology; 1985 May; 36(5):285-92. PubMed ID: 3896044
[TBL] [Abstract][Full Text] [Related]
13. Does oxpentifylline ('Trental') have a place in the treatment of intermittent claudication?
Donaldson DR; Hall TJ; Kester RC; Ramsden CW; Wiggins PA
Curr Med Res Opin; 1984; 9(1):35-40. PubMed ID: 6373157
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of arterial diseases. A study with Trental 400].
Tannenberg G
Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
[TBL] [Abstract][Full Text] [Related]
16. Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
Ambrus JL; Ambrus CM; Taheri SA; Gastpar H; Reddington MM; Taheri P; Kahn EA; Schattman GL; Dean LS; Moore RH
Angiology; 1984 Jul; 35(7):418-26. PubMed ID: 6540538
[TBL] [Abstract][Full Text] [Related]
17. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
Tonak J; Knecht H; Groitl H
Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089
[No Abstract] [Full Text] [Related]
19. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
[TBL] [Abstract][Full Text] [Related]
20. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
Chmiel H; Anadere I; Heimburg P
Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
